Get a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORECreative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MORE HighlightsWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORE HighlightsTo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MORE HighlightsUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.
EXPLORE MORE HighlightsAll products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Creative Biolabs offers extensive range of high-quality IL1RAP CAR products (e.g., CAR vectors, virus particles, cell lines, proteins), as well as advanced solutions to support global customers’ CART projects.
The interleukin 1 receptor accessory protein (IL1RAP), also known as IL1R3, is a co-receptor of the interleukin-1 receptor (IL1R1) and is integral in the IL-1 signaling transmission. The signaling pathways between IL-1RAP and IL-1 superfamily play an important role in tumor development and progression. IL-1RAP has been considered a promising target for the therapy of several hematological and solid cancers.
Anti-IL1RAP CAR-T Expression Test
Creative Biolabs has established a variety of CAR detection products, as well as reliable assay methods to verify CAR expression levels.
Anti-IL1RAP CAR-T Proliferation Test
CART cells show specific proliferation stimulated by target cells, Creative Biolabs has developed a variety of detection methods to test the proliferation capability of CART cells to support our customers' CART projects, including but not limited to flow cytometry for Ki-67 or PCNA marker, cell proliferation dye eFluor 450 staining test.
Fig.1 In vitro proliferation test of anti-IL1RAP CAR T-cells co-cultured with different AML cell lines by flow cytometry.1
Phenotype Analysis of Anti-IL1RAP CAR-T
Phenotypic analysis is often used to detect the relevant functions of CART cells, such as the analysis of cell subpopulations and the analysis of cell states (e.g., activation, apoptosis, exhaustion). To characterize the relevant performance of CART cells, we have launched comprehensive phenotype tests to further provide customers with reliable and robust experimental data.
Fig.2 CD4+/CD8+ T subgroup analysis of anti-IL1RAP CAR-T cells generated from healthy donors or patients with AML.1
Fig.3 Effector T (TE)/memory T (TM) cell subgroup analysis of anti-IL1RAP CAR-T cells generated from healthy donors or patients with AML.1
Anti-IL1RAP CAR-T Cytokine Release Test
Creative Biolabs offers a comprehensive range of cytokine testing services, including intracellular and extracellular cytokine testing. We have established a variety of methods for customers to choose from, including flow cytokine detection, ELISA, multiple cytokine array, etc., and the types of cytokines that can be detected include not limited to IL-2, IL-6, IFN-y, TNF-a.
Fig.4 Intracellular IFN-γ analysis of anti-IL-1RAP CAR-T CD8+ or CD4+ cell subgroup co-cultured with different AML cell lines at 1:5 E:T ratio by flow cytometry.1
Anti-IL1RAP CAR-T In Vitro Cytotoxicity Assay
In vitro cytotoxicity assay can preliminarily verify the specificity and effectiveness of CART cells against target cells, and provide strong support for the subsequent in vivo experimental design. Creative Biolabs supplies customers with a variety of cytotoxicity testing methods, such as LDH cytotoxicity test, flow cytometry cytotoxicity test, RTCA, etc.
Fig.5 In vitro cytotoxicity test of anti-IL1RAP CAR-T cells against different AML cell lines at indicated E:T ratios detected by flow cytometry.1
Anti-IL1RAP CAR-T Cell Therapy Animal Models
For in vivo validation, we offer a variety of animal models (e.g., CDX, PDX models) for our customers to choose from, as well as optimized experimental design to provide better efficacy services.
Fig.6 Schematic diagram of AML xenograft model experiment design for IL1RAP efficacy test.1
Efficacy Test of Anti-IL1RAP CAR-T
Creative Biolabs provides customers with robust in vivo efficacy tests to evaluate the specificity and effectiveness of CART cells against tumor cells.
Fig.7 In vivo efficacy of anti-IL1RAP CAR-T cells in AML xenograft NSG mouse models evaluated by BLI monitoring.1
For CART development, we provide a one-stop service to fully evaluate the therapeutic potential and safety of CAR T cells. In addition to the above evaluation, we also offer the following in vivo tests:
Toxicity Evaluation Anti-IL1RAP CAR-T
Persistence of anti-IL1RAP CAR-T cell
Reference
Loading...
| CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
| XS-1122-YF534 | Anti-IL1RAP KIR CAR (scFv-KIR2DS2-DAP12, XW-534), pCDCAR1 | Human | XW-534 | Mouse | scFv-KIR2DS2 TM&ICD-2A-DAP12 | Lentiviral vector | T Cell | ||
| XS-1122-YF535 | Anti-IL1RAP KIR CAR (scFv-KIR2DS2-DAP12, XW-535), pCDCAR1 | Human | XW-535 | Mouse | scFv-KIR2DS2 TM&ICD-2A-DAP12 | Lentiviral vector | T Cell | ||
| XS-1122-YF536 | Anti-IL1RAP KIR CAR (scFv-KIR2DS2-DAP12, XW-536), pCDCAR1 | Human | XW-536 | Mouse | scFv-KIR2DS2 TM&ICD-2A-DAP12 | Lentiviral vector | T Cell | ||
| XS-1122-YF537 | Anti-IL1RAP KIR CAR (scFv-KIR2DS2-DAP12, XW-537), pCDCAR1 | Human | XW-537 | Mouse | scFv-KIR2DS2 TM&ICD-2A-DAP12 | Lentiviral vector | T Cell | ||
| XS-1122-YF538 | Anti-IL1RAP KIR CAR (scFv-KIR2DS2-DAP12, XW-538), pCDCAR1 | Human | XW-538 | Mouse | scFv-KIR2DS2 TM&ICD-2A-DAP12 | Lentiviral vector | T Cell | ||
| XS-1122-YF2368 | Anti-IL1RAP TCR-ABR (scFv-TCRβ, XW-528) CAR Plasmid, pCDCAR1 | Human | XW-528 | Mouse | scFv-TCRβ | Lentiviral vector | T Cell | ||
| XS-0123-ZP73 | Anti-IL1RAP (81.2) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | 81.2 | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
| XS-0123-ZP74 | Anti-IL1RAP (4B6) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | 4B6 | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
| XS-0123-ZP456 | Anti-IL1RAP (CB-P02) h(scFv-CD3ε) TRuC, pCDTRC1 | Mouse | CB-P02 | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
| XS-0123-ZP724 | Anti-IL1RAP ('02) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | ‘02 | Humanized | scFv-CD3ε | Lentiviral vector | T cell | ||
| XS-0123-ZP725 | Anti-IL1RAP (61) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | 61 | Humanized | scFv-CD3ε | Lentiviral vector | T cell | ||
| XS-0123-ZP726 | Anti-IL1RAP (3H6E10) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | 3H6E10 | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
| XS-0123-ZP727 | Anti-IL1RAP (10D8A7) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | 10D8A7 | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
| XS-0123-ZP728 | Anti-IL1RAP (A3C3) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | A3C3 | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
| XS-0123-ZP729 | Anti-IL1RAP (47) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | 47 | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
| XS-0123-ZP730 | Anti-IL1RAP (75) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | 75 | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
| XS-0123-ZP731 | Anti-IL1RAP (117) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | 117 | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
| XS-0323-ZP73 | Anti-IL1RAP (81.2 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | 81.2 | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
| XS-0323-ZP74 | Anti-IL1RAP (4B6 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | 4B6 | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
| XS-0323-ZP456 | Anti-IL1RAP (CB-P02 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Mouse | CB-P02 | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector |
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION
